HIV i-Base

IAS 2015: news from the Vancouver HIV conference

Featured

START results in full, WHO recommends ART for all, HIV cure research, webcasts access, treatment as prevention in HPTN 052, HIV remission in a teenager, dispersible dolutegravir for kids…

2015 pipeline report launched at IAS

Featured

Activist review of latest research into HIV, HCV and TB: drugs for adults and children, dose optimisation, diagnostics, prevention, cure and vaccines…

May/June HTB now online

Featured

Remembering Professor Martin Fisher, breaking news on the START study, reports from BHIVA, CROI and HIV & Women conferences and much more…

i-Base Q&A on the START study results

What is the START study? The START study is a large international HIV study. It looks at the risks and benefit of early HIV treatment. “Early” is defined as having a CD4 count above 500. Results are compared to a …

Job vacancy: i-Base administrator

Please note that this post has now been filled.   HIV i-Base is looking for a part time office administrator and database manager to join our team. More details on the post are available at this link: http://i-base.info/about-us/volunteering-and-staff-vacancies/ Applications should …

March/April HTB now online

News, comment and reviews of more than 50 studies in 16 articles from CROI 2015 and 4 from the International Drug Resistance Workshop…

CROI 2015: HIV news from Seattle

All about PrEP – 6 studies plus ART prevention, 3-drug ART for PMTCT, HIV drug resistance, new drugs: TAF and maturation inhibitors, why TEMPRANO does not support early ART, weekends-off ART for some young people…

January/February HTB now online

Reports from hepatitis and TB meetings, dolutegravir in England, new London guidelines, India rejects patent for Gilead’s sofosbuvir, plus more…

November/December HTB now online

Stock-outs in the UK, conference reports from Glasgow, BHIVA and South Africa, plus the PROUD and IPERGAY studies and new UK data show urgency of PrEP access…

Poppers linked to permanent and serious vision loss

This is a pre-press article for the November/December edition of HTB. Simon Collins, HIV i-Base Serious vision loss linked to recreational use of poppers has been reported as a case study in this weeks issue of the Lancet. The vision …

Q&A on PrEP in the UK and changes to the HIV PROUD study

NOTE: Please see this updated information about the PROUD results and access to PROUD in the UK. http://i-base.info/uk-proud-study-to-provide-prep-earlier-than-expected The following Q&A was produced by i-Base about PrEP in the UK including recent changes to the PROUD study. Participants in the …

September/October HTB now online

Reports from the 54th ICAAC and IAS 2014 conferences, newly approved drugs for HIV and hepatitis C, new UK guidelines for pregnancy and PEP, plus a potential new approach for PML…

July/August HTB now online

Ten reports from AIDS 2014, coverage from paediatric and INTEREST workshops, London guidelines, dolutegravir access in the UK, plus lots more…

Post navigation